The Chiropractic Research Studies Worth Knowing (and How to Cite Them Honestly)

You have more evidence behind you than you probably use.

The last decade produced a genuinely strong body of research supporting what chiropractors do for spine pain — published in JAMA, in Annals of Internal Medicine, and in a clinical guideline from the largest physician organization in the country. None of it came from us. All of it is citable.

Most doctors know these papers exist and can't quite cite them in a conversation. That's the gap this closes. Seven papers, what each one found, and — just as usefully — the pushback you'll get on each and the answer to it. Knowing the counterargument before it arrives is what turns a citation into a persuasive one.

Because here's the thing about the audiences that matter most — the skeptical MD, the hospital system, the attorney evaluating you as an expert: they respect precision far more than enthusiasm. A chiropractor who can say "the effect size is comparable to NSAIDs with a better risk profile, and here's the meta-analysis" is a chiropractor who gets referrals. That's a stronger position than any superlative, and it's available to you today.

1. Paige et al., JAMA, 2017 — spinal manipulation for acute low back pain

Citation: Paige NM, Miake-Lye IM, Booth MS, et al. Association of Spinal Manipulative Therapy With Clinical Benefit and Harm for Acute Low Back Pain: Systematic Review and Meta-analysis. JAMA. 2017;317(14):1451-1460.

A systematic review and meta-analysis of 26 randomized controlled trials examining spinal manipulative therapy for acute low back pain, defined as six weeks or less.

What it found. Fifteen trials covering 1,711 patients provided moderate-quality evidence of a statistically significant association between SMT and improvement in pain. Twelve trials covering 1,381 patients provided moderate-quality evidence of improvement in function. Adverse events were minor and transient — increased pain, stiffness, headache.

Why it matters. It's in JAMA. When a physician asks for evidence, this is the paper to hand them, because they don't have to take the journal's credibility on faith.

The pushback, and your answer. Someone will say the effect size is small. It is — the authors describe the benefit as modest, roughly comparable to what Cochrane reports for NSAIDs, with heterogeneity across trials.

That's not a weakness in your position, it's the strongest thing you can say. Comparable benefit to a first-line drug, without the GI bleeding, kidney risk, or interaction profile. Say it first and the conversation is over. Claim dramatic superiority instead and a physician who reads the paper will discount everything else you tell them.

2. Qaseem et al., Annals of Internal Medicine, 2017 — the ACP guideline

Citation: Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017;166(7):514-530.

This is arguably the single most consequential document for the profession in the last decade, and it wasn't written by chiropractors.

What it found. The ACP recommends that clinicians and patients treat acute or subacute low back pain with non-drug therapies — superficial heat, massage, acupuncture, or spinal manipulation — as the first approach. If drug therapy is chosen, NSAIDs or skeletal muscle relaxants. For chronic low back pain, spinal manipulation appears among the first-line non-pharmacologic options alongside exercise, multidisciplinary rehabilitation, acupuncture, mindfulness-based stress reduction, tai chi, and yoga.

Why it matters. A guideline from the largest medical specialty organization in the United States placing spinal manipulation as a first-line option is a positioning fact, not a marketing claim. It's the reference that opens conversations with medical referral sources.

The pushback, and your answer. Manipulation is listed among several non-drug options, not above them, and the evidence grades vary by outcome. Fine — you don't need it ranked first. You need it ranked ahead of medication, and it is. The ACP put non-drug care before NSAIDs in the treatment sequence, and spinal manipulation is on that list. For a referral conversation, that's the whole point.

3. Chou et al., Annals of Internal Medicine, 2017 — the evidence review behind the guideline

Citation: Chou R, Deyo R, Friedly J, et al. Nonpharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):493-505.

The systematic review the ACP guideline was built on.

Why it matters. If someone challenges the guideline, this is the underlying evidence base. Citing the review rather than only the guideline signals you've read past the headline, which is a meaningfully different conversation with a physician.

4. Goertz et al., JAMA Network Open, 2018 — the military trial

Citation: Goertz CM, Long CR, Vining RD, Pohlman KA, Walter J, Coulter I. Effect of Usual Medical Care Plus Chiropractic Care vs Usual Medical Care Alone on Pain and Disability Among US Service Members With Low Back Pain: A Comparative Effectiveness Clinical Trial. JAMA Netw Open. 2018;1(1):e180105.

A three-site pragmatic comparative effectiveness trial enrolling 750 active-duty US service members aged 18 to 50 with low back pain, randomized to usual medical care alone or usual medical care plus chiropractic care.

What it found. Adding chiropractic care to usual medical care produced moderate short-term improvements in low back pain intensity and disability, along with better patient satisfaction.

Why it matters. The design is what makes it valuable. It isn't chiropractic versus medicine — it's medicine versus medicine plus chiropractic. That's the question a health system or an integrated practice actually asks, and it's a far easier conversation than a head-to-head framing. The population is also young, healthy, and highly motivated to function, which removes a common confounder.

The pushback, and your answer. Pragmatic trials can't blind participants, so expectation effects are in play, and several authors disclosed relationships with chiropractic organizations. Name both yourself before anyone raises them — it costs you nothing and it establishes that you read the paper rather than a summary of it. Then point out that pragmatic design is a feature here, not a flaw: it measures what actually happens when chiropractic is added to real care in a real system, which is the question a health system is asking.

5. Shannon et al., BMC Complementary Medicine and Therapies, 2026 — the 52-week follow-up

Citation: Shannon ZK, Long CR, Vining RD, McCarey J, Walter JA, Coulter ID, Goertz CM. Longer-term chiropractic care outcomes for US active-duty military personnel with low back pain: secondary analysis of a pragmatic clinical trial. BMC Complement Med Ther. 2026;26(1):185.

A secondary analysis extending the 2018 military trial out to 52 weeks.

Why it matters. The most common and most legitimate criticism of manipulation research is that follow-up is short — plenty of evidence at six weeks, much less at a year. This paper directly addresses that gap in a trial population that was already well characterized. It's also recent enough that most people in the profession haven't read it yet, which makes it useful in a conversation.

6. The Spine Journal, 2018 — manipulation and mobilization for chronic low back pain

Citation: Manipulation and mobilization for treating chronic low back pain: a systematic review and meta-analysis. The Spine Journal. 2018.

The Paige meta-analysis covered acute pain only. This one covers chronic.

What it found. Moderate-quality evidence that manipulation and mobilization are likely to reduce pain and improve function in chronic low back pain, with manipulation appearing to produce a larger effect than mobilization. Both were assessed as safe. Multimodal programs were identified as a promising direction.

Why it matters. Chronic low back pain is where most practice populations actually live, and it's where the opioid conversation is. This fills the gap the acute-pain literature leaves.

7. Shekelle et al., VA evidence review, 2017 — acute neck and low back pain

Citation: Shekelle PG, Paige NM, Miake-Lye IM, et al. The Effectiveness and Harms of Spinal Manipulative Therapy for the Treatment of Acute Neck and Lower Back Pain: A Systematic Review. Washington (DC): Department of Veterans Affairs (US); 2017.

The fuller Veterans Affairs report behind the JAMA paper, covering neck pain as well as low back.

Why it matters. Two reasons. It extends to cervical presentations, where the literature is thinner. And its provenance — a VA evidence synthesis program — carries weight with exactly the institutional audiences that are hardest to persuade.

How to actually use these

Cite the limitation before someone else does. "The effect size is modest — roughly comparable to NSAIDs, with fewer risks" is a more persuasive sentence than any superlative, because it demonstrates you've read the paper rather than a summary of it.

Match the study to the audience. ACP guideline for a physician. The military trial for a health system or employer. Paige for a patient who wants to know whether this is legitimate. The Spine Journal review for a chronic pain conversation.

Never claim a study says something it doesn't. The single fastest way to lose a referral relationship is to send a physician a paper that doesn't support the claim you attached to it. They will read it. Assume they will read it.

Link to the source. When you reference research on your website or in patient materials, link to PubMed or the journal. It costs you nothing and it changes how the claim reads.

Keep the list short. Seven papers you know well beat forty you've skimmed. These seven cover acute, chronic, guideline positioning, integrated care, and long-term follow-up — which is most of what any conversation requires.

Know where your ground is strongest

You don't have to defend every claim ever made in the profession. You only have to be excellent on the ground you're standing on — and on spine pain, that ground is solid.

Where the evidence is strong: low back pain, acute and chronic. Meta-analyses in JAMA and The Spine Journal, a first-line recommendation from the ACP, and a 750-patient trial in a military health system. This is the territory where you can be completely confident, and it also happens to be the majority of what walks through your door.

Where it's developing: neck pain and cervicogenic headache. Real support, thinner literature. Cite it with the same accuracy and you're fine.

Where you're out ahead of the evidence: most non-musculoskeletal claims. Not disproven — under-studied. The honest and effective move is simply not to lead with them in a professional conversation. You have plenty without them.

Pick your ground deliberately and you never have to be defensive. The doctor who says "spine pain is where the research is strongest and that's what I'm talking to you about" is in a far stronger position than one defending everything at once.

Frequently asked questions

What is the strongest evidence for chiropractic care? Spinal manipulation for acute and chronic low back pain, supported by meta-analyses in JAMA and The Spine Journal and by the American College of Physicians guideline recommending non-drug approaches including spinal manipulation as first-line care.

Does the American College of Physicians recommend spinal manipulation? Yes. The 2017 ACP guideline lists spinal manipulation among the non-pharmacologic options for acute, subacute, and chronic low back pain, ahead of drug therapy in the treatment sequence.

How large is the benefit of spinal manipulation? Modest. The JAMA meta-analysis authors described the benefit for acute low back pain as small, and roughly comparable in size to that of NSAIDs — with the relevant difference being the risk profile rather than the effect size.

Is spinal manipulation safe? The major reviews report minor, transient adverse events such as increased soreness, stiffness, and headache. Serious adverse events are rare in the trial literature. Screening and informed consent remain standard of care.

How should I share research with a referring physician? Send the actual paper, name the limitations yourself, and make sure your claim matches what the study found. Overstating a finding to a physician who will read it costs more than the referral you were trying to earn.

Where this fits

Being able to speak accurately about the evidence is a practice asset — in patient conversations, in attorney relationships, and in any integrated care setting. It's also the thing most practices assume they have and don't.

We write about the evidence and the business of practice with the same standard in our weekly email.